Please try another search
For the nine months ended 30 September 2016, Nobilis Health Corp revenues increased 32% to $183.8M. Net loss totaled $2.9M vs. income of $6M. Revenues reflect medical services segment increase of 86% to $166.9M, Marketing & Factoring segment increase of 46% to $16.9M. Net loss reflects General and administrative increase of 57% to $85.7M (expense), Drugs and supplies increase of 78% to $39.7M (expense).
Period Ending: | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 |
---|---|---|---|---|
Total Revenue | 70.68 | 61.87 | 51.27 | 90.02 |
Gross Profit | 91.27 | |||
Operating Income | -1.1 | 0.06 | -9.69 | 20.95 |
Net Income | -2.76 | 4.81 | -4.96 | 44.8 |
Period Ending: | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 |
---|---|---|---|---|
Total Assets | 240.98 | 232.94 | 228.17 | 242.03 |
Total Liabilities | 110.67 | 101.72 | 103.64 | 115.69 |
Total Equity | 130.31 | 131.22 | 124.53 | 126.34 |
Period Ending: | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | 9.34 | 8.18 | 4.46 | 6.71 |
Cash From Investing Activities | -4.85 | -3.49 | -1.98 | -11.65 |
Cash From Financing Activities | -0.55 | -1.54 | -1.92 | 13.03 |
Net Change in Cash | 3.95 | 3.16 | 0.56 | 8.1 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review